美国Tissue Growth Technologies TGT
TGT是全世界第一家将生物反应器产品化和模组化的公司，凭借着五十多年的设计实务经验，完整开发一系列精巧模组化的生物组织工程技术系统，也可依使用者需求客制化设备规格。


to provide technologically advanced bioreactor solutions for creating clinically relevant tissue engineered medical devices for new generation therapies.

Vision Statement: Engineering Bioreactors for a Better Tomorrow

Tissue Growth Technologies was founded in 1990 as EnduraTEC Systems Corporation, with the charter of becoming a world-class provider of material test instruments to the biomedical community. Over the subsequent decade, the company introduced many new test equipment innovations and built an international customer base.

In 2000, the company recognized the need for mechanical stimulation for tissue growth applications and began developing a line of associated instruments. By leveraging the company's broad expertise in controls, precision low force motors and transducers, the company introduced its first ITEMs Tissue Growth Instruments soon thereafter.

In 2004, the company sold its material testing product lines while retaining its tissue growth assets, allowing greater focus on the development of new products for the tissue growth industry.

Building upon experience acquired over 16 years, the newly renamed Tissue Growth Technologies has set out to become a premier supplier of tissue engineering bioreactors and associated products within this emerging industry. Having placed systems into corporate, academic, and governmental research labs across both United States and international markets, TGT has steadily grown both revenues and resources, and houses design, manufacturing, validation, and laboratory facilities. The team’s experienced scientists and engineers are continually looking for opportunities to assist the tissue engineering market.